Form 4 for GKOS GLAUKOS Corp
Accepted 2024-07-09 00:00:00 ET · period of report 2024-07-05 · accession 0001415889-24-019438 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-07-09 | 2024-07-05 | GKOS | Gilliam Joseph E | Pres, COO | S - Sale+OE | $121.39 | -2,250 | 101.8K | -2% | -$273.1K |
| D | 2024-07-09 | 2024-07-05 | GKOS | Gilliam Joseph E | Pres, COO | M - OptEx | $69.30 | +2,250 | 104.1K | +2% | +$155.9K |
| D | 2024-07-09 | 2024-07-05 | GKOS | Gilliam Joseph E | Pres, COO | M - OptEx | $69.30 | -2,250 | 4,981 | -31% | -$155.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-05 | S | D | 2,250 | $121.39 | 101,845 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $121.28 to $121.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. (F1) Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person. |
| 2 | Common | Common Stock | 2024-07-05 | M | A | 2,250 | $69.30 | 104,095 | D | — | — | (F1) Includes 76,419 restricted stock units that have not yet vested or been delivered to the Reporting Person. |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-07-05 | M | D | 2,250 | $69.30 | 4,981 | D | $69.30 · — to 2029-03-14 | 2,250 Common Stock | (F5) This option was granted on March 14, 2019 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date. |